Theophylline Tablet, Extended Release
Product Images NDC 72789-441

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 72789-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789441 Label (72789441)

Theophylline extended-release tablets, USP 300 mg. The label shows the product name and strength prominently, indicating 100 tablets per container. It specifies the active ingredient as Theophylline (Anhydrous) USP 300 mg per tablet. The product is marked Rx Only and is manufactured by Strides Pharma Science Limited, India, and marketed by PD-Rx Pharmaceuticals, Inc. The label also includes storage instructions, a barcode, and regulatory information including NDC 72789-441-01.*

FDA Label Image

Structure-theophylline (7487d300 1a59 4410 84ae 8a36b24b15a9 01)

Chemical structure diagram of the active ingredient Theophylline. The image depicts the molecular formula and bonds characteristic of Theophylline.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.